Lanoxin Pediatric

   
Google
 
Web NewDrugInformation.com

Lanoxin Pediatric


Drug - Lanoxin Pediatric
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Digoxin
Multiple ingredients are in alphabetical order.

Strength - 0.1MG/ML
The potency of the active ingredient(s), Digoxin. May repeat for multiple part products.

Applicant - GLAXOSMITHKLINE
The firm name holding legal responsibility for Lanoxin Pediatric. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 009330
The FDA assigned number to Lanoxin Pediatric. Format is nnnnnn.

Product Number - 004
The FDA assigned number to identify Lanoxin Pediatric. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Lanoxin Pediatric was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Lanoxin Pediatric. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Lanoxin Pediatric is in. Format is RX, OTC, DISCN.

Applicant Full Name - Glaxosmithkline
The full name of the firm holding legal responsibility for the new application of Lanoxin Pediatric.

Lanoxin Pediatric